<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412019001200004</article-id>
<article-id pub-id-type="doi">10.24245/gom.v87i12.3439</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Diferencia en el índice neutrófilos-linfocitos entre pacientes con síndrome de ovario poliquístico y sanas]]></article-title>
<article-title xml:lang="en"><![CDATA[Difference in neutrophil/lymphocyte index between patients with polycystic ovarian syndrome and healthy women]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carranza-Lira]]></surname>
<given-names><![CDATA[Sebastián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Acosta]]></surname>
<given-names><![CDATA[Grecia Carmín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Ángeles]]></surname>
<given-names><![CDATA[Luis Claudio Erick]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital de Ginecoobstetricia 4, Luis Castelazo Ayala Unidad Médica de Alta Especialidad ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital de Ginecoobstetricia 4, Luis Castelazo Ayala Unidad Médica de Alta Especialidad ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital de Ginecoobstetricia 4, Luis Castelazo Ayala Unidad Médica de Alta Especialidad Servicio de Ginecología Endocrina]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<volume>87</volume>
<numero>12</numero>
<fpage>802</fpage>
<lpage>806</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412019001200004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412019001200004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412019001200004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO:  Determinar la correlación del índice neutrófilos-linfocitos entre mujeres sanas y con síndrome de ovario poliquístico con las concentraciones de glucosa, lípidos y andrógenos.  MATERIALES Y MÉTODOS:  Estudio descriptivo, retrospectivo, transversal y comparativo efectuado en el Hospital de Gineco-Obstetricia Luis Castelazo Ayala, entre julio de 2016 y febrero de 2019. Se estudiaron mujeres con síndrome de ovario poliquístico en quienes se cuantificaron: glucosa, lípidos, testosterona, androstenediona y sulfato de dehidroepiandrosterona. Con base en el reporte de la biometría hemática se calculó el índice neutrófilos-linfocitos. Los resultados se compararon con controles sanas estudiadas por infertilidad. Para el análisis estadístico se utilizó U de Mann-Whitney y análisis de correlación de Spearman.  RESULTADOS:  Se estudiaron 112 pacientes que se dividieron en dos grupos: el grupo 1 con síndrome de ovario poliquístico (n = 63) y grupo 2 mujeres sanas (n = 49). La mediana de la edad del grupo 1 fue 27 (14-39) la del grupo 2: 28 (16-41) años, sin diferencia estadísticamente significativa entre ambos ni entre los grupos en concentraciones de glucosa, colesterol y triglicéridos. El índice neutrófilos-linfocitos fue significativamente mayor en el grupo con síndrome de ovario poliquístico: 1.9 (0.9-7.4) vs 1.4 (0.8-3.9), p &lt; 0.000, respectivamente.  CONCLUSIÓN:  El síndrome de ovario poliquístico se asocia con un proceso inflamatorio crónico y mayor riesgo cardiovascular.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE:  To determine the difference in the neutrophil/lymphocyte index between PCOS patients and healthy women.  MATERIALS AND METHODS:  Descriptive, retrospective, cross-sectional, comparative study. Women with PCOS were studied in which glucose, lipids, testosterone, androstenedione and dehydroepiandrosterone sulfate were measured, also a blood count was performed, and the neutrophil/lymphocyte index was calculated. The results were compared with healthy controls studied for infertility. For statistical analysis, Mann-Whitney U and Spearman correlation analysis were used.  RESULTS:  112 patients divided as follows were studied: group I with PCOS (n = 63) and group II healthy women (n = 49). The median age was for group I: 27 (14-39) and group II: 28 (16-41) years without statistically significant difference between them, also there were not between the groups in the concentrations of glucose, cholesterol and triglycerides. The neutrophil/lymphocyte index was significantly higher in the group with PCOS, 1.9 (0.9-7.4) vs 1.4 (0.8-3.9), p &lt; 0.000, respectively.  CONCLUSION:  PCOS is associated with a chronic inflammatory process that may confer greater cardiovascular risk.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Índice neutrófilos-linfocitos]]></kwd>
<kwd lng="es"><![CDATA[glucosa]]></kwd>
<kwd lng="es"><![CDATA[lípidos]]></kwd>
<kwd lng="es"><![CDATA[enfermedades cardiovasculares]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo]]></kwd>
<kwd lng="es"><![CDATA[androstenediona]]></kwd>
<kwd lng="en"><![CDATA[Neutrophil/lymphocyte index]]></kwd>
<kwd lng="en"><![CDATA[Glucose]]></kwd>
<kwd lng="en"><![CDATA[Lipids]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular diseases]]></kwd>
<kwd lng="en"><![CDATA[Risk factors]]></kwd>
<kwd lng="en"><![CDATA[Androstenedione]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Azziz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prevalence and features of the polycystic ovary syndrome in an unselected population]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2004</year>
<volume>89</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2745-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2004</year>
<volume>81</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-25</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dahan]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Reaven]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome]]></article-title>
<source><![CDATA[Endocrine]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study]]></article-title>
<source><![CDATA[Int J Cancer]]></source>
<year>2017</year>
<volume>140</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>285-91</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teede]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International PCOS Network Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2018</year>
<volume>110</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>364-79</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2017</year>
<volume>45</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1403-12</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pant]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammation and atherosclerosis--revisited]]></article-title>
<source><![CDATA[J Cardiovasc Pharmacol Ther]]></source>
<year>2014</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>170-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orio Jr]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2005</year>
<volume>90</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>2-5</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[White blood cell differential counts in patients with polycystic ovary syndrome a pilot study on Chinese women]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2013</year>
<volume>170</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>162-4</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome]]></article-title>
<source><![CDATA[Brain Behav Immun]]></source>
<year>2008</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>177-84</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults An observational study]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2019</year>
<volume>98</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[Diabetes Metab Res Rev]]></source>
<year>2007</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>111-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furuncuoglu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>2016</year>
<volume>20</volume>
<page-range>1300-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aydin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neutrophil/lymphocyte ratio in obese adolescents]]></article-title>
<source><![CDATA[North Clin Istanb]]></source>
<year>2015</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>87-91</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yilmaz]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome]]></article-title>
<source><![CDATA[J Endocrinol Invest]]></source>
<year>2016</year>
<volume>39</volume>
<page-range>45-53</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
